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Abstract Individuals with obesity do not represent a single homogenous group in terms of
cardio-metabolic health prospects. The concept of metabolically healthy obesity is a
crude way of capturing this heterogeneity and has resulted in a plethora of research
linking to future outcomes to show that it is not a benign condition. By contrast, very
few studies have looked back in time and modelled the life course processes and
exposures that explain the heterogeneity in cardio-metabolic health and morbidity
and mortality risk among people with the same body mass index (BMI) (or waist
circumference or percentage body fat). The aim of the Medical Research Council
New Investigator Research Grant (MR/P023347/1) ‘Body size trajectories and
cardio-metabolic resilience to obesity in three United Kingdom birth cohorts’ is to
reveal the body size trajectories, pubertal development patterns and other factors
(e.g. early-life adversity) that might attenuate the positive associations of adulthood
obesity makers (e.g. BMI) with cardio-metabolic disease risk factors and other
outcomes, thereby providing some degree of protection against the adverse effects of
obesity. This work builds on the Principle Investigator’s previous research as part of
the Cohort and Longitudinal Studies Enhancement Resources initiative and focuses
on secondary data analysis in the nationally representative UK birth cohort studies
(initiated in 1946, 1958 and 1970), which have life course body size and exposure
data and a biomedical sweep in adulthood. The grant will provide novel evidence on
the life course processes and exposures that lead to some people developing a cardio-
metabolic complication or disease or dying while other people with the same BMI do
not. This paper details the grant’s scientific rationale, research objectives and
potential impact.
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Cardio-metabolic resilience to obesity
According to the latest data from the Non-
Communicable Diseases Risk Factor Collaboration
(2017), the number of adults worldwide with obesity
increased from approximately 100 million to 671
million between 1975 and 2016, with an additional
1.3 billion in the overweight range. While this obe-
sity epidemic is associated with a wide range of
adverse mental and physical health conditions and
societal costs (Withrow & Alter 2011; GBD 2015
Obesity Collaborators et al. 2017), individuals with
obesity do not form a single homogenous group with
the same health and disease risks. Indeed, it has been
estimated that in 2015 nearly 40% of global deaths
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due to common non-communicable diseases occurred
in individuals who were not obese according to a
body mass index (BMI) greater or equal to 30 kg/m2
(GBD 2015 Obesity Collaborators et al. 2017). This
finding reflects the limitation of BMI in measuring
adiposity and disease risk (Prentice & Jebb 2001;
Flegal et al. 2009), but also illustrates that there is
clearly substantial heterogeneity in cardio-metabolic
health among people with the same or at least simi-
lar BMI values.
Since the 1980s, the term metabolically healthy obe-
sity (MHO) has been used to describe the sub-group of
individuals who are obese (normally according to BMI
or waist circumference) but do not have any, or only
minimal, cardio-metabolic complications (typically
including hypertension, dyslipidemia and hyper-
glycaemia). The idea that someone can be obese yet
metabolically healthy has been highly controversial and
widely debated (Piepoli et al. 2016; Stefan et al. 2018).
A plethora of epidemiological studies have largely dis-
pelled MHO as an unhelpful and misleading construct,
namely because individuals with MHO (1) tend to
develop cardio-metabolic complications and transi-
tion to being unhealthy more frequently than their
non-obese counterparts (Bobbioni-Harsch et al. 2012;
Appleton et al. 2013; den Engelsen et al. 2013;
Soriguer et al. 2013; Bell et al. 2015a,b; Hamer et al.
2015; Guo & Garvey 2016) and, therefore, (2) have
greater incidence of various mortality and morbidity
outcomes (e.g. coronary heart disease and type 2 dia-
betes) (Fan et al. 2013; Hinnouho et al. 2013, 2015;
Aung et al. 2014; Gunter et al. 2015; Sung et al. 2015;
Murphy et al. 2016; Caleyachetty et al. 2017; Lassale
et al. 2018). As such, MHO is not a benign condition
but rather an intermediate state before the development
of cardio-metabolic abnormalities. In many ways, it is
also a man-made artefact: categorising a population
into sub-groups by dichotomising measures, such as
BMI and blood pressure, is nearly always going
to identify a relatively small group who are obese
(BMI ≥30 kg/m2) but do not have hypertension (blood
pressure <140/90 mmHg), for example. However, this
group with so-called ‘healthy obesity’ is always going
to have higher average blood pressure than the much
larger group who are not obese (BMI <30 kg/m2) and
do not have hypertension (blood pressure <140/
90 mmHg). Such inherent baseline differences in risk
factors between the healthy obese and healthy non-
obese groups are reported in the descriptive statistics
table of most papers on this topic and are largely
responsible for known differences in mortality risk
between these two groups (Johnson et al. 2018b).
Documented associations of MHO with disease or mor-
tality risk might, therefore, be viewed as an artefact.
As surmised in a recent commentary (Johnson
2018), variation in cardio-metabolic health and dis-
ease risk at any given BMI value (or even waist cir-
cumference etc.) is undeniable, but the concept of
MHO is a crude way of capturing this heterogeneity.
A lot of work over the decades has looked forward in
time, finding and using somewhat obvious results (i.e.
the most obese and unhealthy have the worst progno-
sis, the most normal weight and healthy have the best
prognosis, and any group in between has intermediate
prognosis) to argue that healthy obesity doesn’t really
exist. By contrast, very few studies have looked back
in time and modelled the life course processes and
exposures that explain why some people develop a
disease or die while other people with the same BMI
do not.
Body size trajectories and life course
exposures
The seminal publication of Abraham et al. (1971) was
one of the first studies to investigate the consequences
of early-life characteristics for adulthood cardiovascu-
lar disease, followed closely, of course, by the
pioneering work of Barker et al. (1989). By collecting
long-term follow-up data on ~700 men who attended
schools in Hagerstown, MD, US, between 1923 and
1928 and had weight recorded at the age of 9–
13 years, Abraham et al. (1971) were able to show
that rates of some cardiovascular diseases were highest
among the group of individuals who were most over-
weight in adulthood but below average weight in
childhood. This type of analysis, based on simple
cross-tabulations, also tells us about the childhood to
adulthood trajectory that incurred the greatest disease
risk: morbidity was greatest in overweight men who
were below average weight children, so the greatest
disease risk occurred in individuals who gained the
most weight or had the steepest trajectory between
childhood and follow-up, 35–40 years later. These
results essentially represent a statistical interaction,
in which the well known positive association of
adulthood obesity with cardiovascular disease risk is
modified by childhood weight status. That is, the
cardio-metabolic complications of adulthood obesity
were less pronounced for individuals who were also
overweight in childhood, thereby inadvertently demon-
strating how high childhood BMI might provide some
degree of cardio-metabolic protection against the
adverse consequences of obesity in adulthood.
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Subsequent publications that have replicated this type
of analysis have not typically discussed their findings
within the context of healthy obesity (Juonala et al.
2011; Park et al. 2013; Bjerregaard et al. 2018), but
from this literature it is clear that high childhood BMI
is not a powerful disease risk factor in itself because
the majority of morbidity and mortality occurs in
adults who were normal weight children (Llewellyn
et al. 2016), in agreement with the Abraham et al.
(1971) findings.
Based on their work of the adiposity rebound,
Rolland-Cachera and Peneau (2013) have proposed
that there are two main BMI trajectories that lead to
adulthood obesity. The first is characterised by being
big at all ages due to healthy levels of both fat and
fat-free mass, while the second is characterised by low
or normal BMI in infancy, an early-adiposity rebound,
and subsequently an unhealthy level of fat accumula-
tion. The first type of trajectory has been hypothesised
to be associated with MHO in adulthood, while the
second is clearly more deleterious and, as supporting
evidence, is more characteristic of individuals born
during (compared to before) the obesity epidemic
era (Johnson et al. 2012a,b, 2013b, 2015). Few stud-
ies have, however, investigated how different BMI tra-
jectories might lead to obesity but incur different
health and disease risks. A recent paper using data
from the 1966 Northern Finland Birth Cohort related
BMI trajectories (summarised by timing and magni-
tude of infant BMI peak and adiposity rebound) to
weight and health status at 31 years of age, but likely
found spurious results because of the very low number
of MHO individuals in their sample (9 men; 22
women) (Nedelec et al. 2018). Matta et al. (2016)
have shown that being born with a birthweight appro-
priate-for-gestational age (AGA) confers a higher
probability of adulthood MHO than being born
small-for-gestational age (SGA), in line with the
hypothesis of Rolland-Cachera and Peneau (2013).
Further, Johnson et al. (2017) have demonstrated that
higher infant BMI might offer protection against the
deleterious effects of adulthood obesity because of
gains in fat-free mass. This is supported by the study
of Bouhours-Nouet et al. (2008) that found higher
infant weight gain to protect obese children (n = 117)
from truncal adiposity and insulin resistance, which is
intriguing given the evidence linking rapid infant
weight gain to increased obesity risk (Druet et al.
2012). Beyond infancy, Salonen et al. (2009) found
higher BMI at ages 2–11 years to protect obese adults
(n = 499) from the metabolic syndrome, whereas
Howe et al. (2014) found no robust evidence that
rapid BMI gain between 7 and 13 years was protective
for cardio-metabolic health in obese Danish men
(n = 284). The two studies that have investigated early-
onset obesity also reported equivocal results (Brochu
et al. 2001; Howe et al. 2014). In summary, this litera-
ture base is small and inconclusive, with most studies hav-
ing a limited sample size and focusing on just one body
size trait. Perhaps the most reliable, consistent evidence is
that being obese for a longer duration and to a greater
intensity predicts being metabolically unhealthy
(Mongraw-Chaffin et al. 2016; Zamrazilova et al. 2016).
Body size trajectories are, of course, an obvious
starting point for exploring the life course processes
that might provide cardio-metabolic resilience to obe-
sity, and one study has augmented this work by look-
ing at pubertal timing. In that paper, Bleil et al.
(2012) observed that an earlier age at menarche was
associated with increased odds of metabolically
unhealthy obesity among 989 women aged 25–
45 years, again tying in with the hypothesis of
Rolland-Cachera and Peneau (2013) because advanced
pubertal development is related to an earlier adiposity
rebound and childhood obesity (Ahmed et al. 2009;
Johnson et al. 2013a; German et al. 2015). But, in
order to intervene and prevent or delay the cardio-
metabolic complications of obesity, modifiable targets
that are more tangible than BMI trajectory and puber-
tal timing are needed. The problem is that, while the
cross-sectional correlates of MHO are extensively doc-
umented, we know almost nothing about which, and
how, life course exposures (operating during gestation,
early life and beyond) explain heterogeneity in health
and disease risk at any given BMI value (Phillips
2017; Robson et al. 2018). Such information would
not only be useful in understanding which obese indi-
viduals have the lowest morbidity and mortality risks,
but also in understanding which non-obese individuals
have the highest.
Current and future research objectives
The aim of the UK Medical Research Council (MRC)
New Investigator Research Grant (MR/P023347/1)
‘Body size trajectories and cardio-metabolic resilience
to obesity in three United Kingdom birth cohorts’ is to
reveal the body size trajectories and pubertal develop-
ment patterns that might attenuate the positive associa-
tions of adulthood obesity with cardio-metabolic
disease risk factors, thereby providing cardio-metabolic
resilience to obesity. This work will also quantify the
trajectories and patterns that might result in some nor-
mal weight adults having poor health prospects. The
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focus will be on secondary data analysis in nationally
representative UK birth cohort studies which have life
course body size data and a biomedical sweep in adult-
hood, namely the MRC National Survey of Health and
Development (1946 NSHD; Wadsworth et al. 2006),
the National Child Development Study (1958 NCDS;
Power & Elliott 2006) and the British Birth Cohort
(1970 BCS; Elliott & Shepherd 2006). As part of the
Cohort and Longitudinal Studies Enhancement
Resources (CLOSER) initiative, the Principle Investiga-
tor (WJ) has already harmonised the body size data
across these (and other UK) birth cohorts studies to
investigate secular trends in obesity development (John-
son et al. 2015), socio-economic inequalities in child-
hood and adulthood body size (Bann et al. 2017, 2018)
and the contribution of infant weight gain to the adoles-
cent obesity epidemic (Johnson et al. 2018a). This new
grant is a continuation of this work, augmenting the
harmonised body size data set with adulthood cardio-
metabolic measures.
Rather than having to define MHO, which is an
inherently limited construct, the analysis plan focuses
on developing models that treat continuous variables
as continuous and estimate how the relationship of
adulthood BMI with some risk factors (e.g. HbA1c)
is modified by body size trajectories of pubertal
development patterns. Using this type of interaction
nods back to the Abraham et al. study (1971).
Briefly, cardio-metabolic risk factors will be consid-
ered separately and in composite outcome variables.
Body size trajectories will be captured by (1) condi-
tional change measures (that represent starting size
and rate of change during different age periods),
(2) traits from multilevel growth curve models (e.g.
area under the BMI trajectory, length of time obese
and age of obesity onset) and (3) latent trajectory
classes from mixture models (Johnson 2015). Puber-
tal development patterns will be captured by individ-
ual as well as composite variables. Models will be
built in each cohort study separately, and where
appropriate meta-analysis techniques will be used to
pool estimates and investigate between-study hetero-
geneity. Structural equation modelling will be used to
determine the direct and indirect paths between body
size trajectories, patterns of pubertal development
and adulthood BMI and cardio-metabolic risk. Fur-
ther work utilising the sequential nature of the
cohorts (i.e. 1946, 1958 and 1970) will quantify, and
describe the contribution of between-cohort differ-
ences in body size trajectories and pubertal develop-
ment patterns to, any secular trend in cardio-
metabolic resilience to obesity.
The grant will also be used as a springboard to
develop a much larger and comprehensive programme
of research in this field. Work using the English Longi-
tudinal Study of Ageing (Steptoe et al. 2013) to investi-
gate how the MHO-mortality association strengthens
when the referent group comprises stable healthy non-
obese individuals identified from repeat biomedical
assessments has already been published (Hamer et al.
2017), as has work using the Whitehall II study
(Marmot et al.1991) to show how the MHO-mortality
association attenuates after accounting for inherent
baseline differences in risk factors (Johnson et al.
2018b). Mortality data are also available in the NSHD,
NCDS and BCS and, in collaboration with colleagues at
University College London (UK), there are plans to link
these data to the CLOSER harmonised body size data
set for epidemiological investigation. The NSHD argu-
ably has the richest life course and biomedical data,
and a PhD student is working with WJ at Loughbor-
ough University to investigate how early-life adversity
and lifestyle behaviours might provide cardio-metabolic
resilience to obesity in this cohort. Other regional birth
cohort studies in the UK have more frequent body size
data in childhood (e.g. the Avon Longitudinal Study of
Parents and Children; Boyd et al. 2013), providing the
opportunity to model fine-tuned trajectories that lead
to adulthood obesity but have different cardio-
metabolic profiles. Inside and outside of the UK, there
are also cohorts that have the necessary data to model
which and how exposures explain heterogeneity in the
consequences of other anthropometric indicators of dis-
ease risk (e.g. rapid infant weight gain). Finally, while
this evolving research programme will naturally lend
itself to the use of longitudinal birth cohort data, large-
scale survey data could be used to describe world-
wide and temporal variation in BMI-risk factor
associations.
Knowledge exchange and impact
Body size trajectories have played a central part in the
evolution of life course epidemiology, and this grant is
the next step in refining our understanding of their
role in disease development. The results will constitute
a significant advancement in our understanding of
how, when and in whom some degree of cardio-
metabolic resilience to obesity develops. We envisage
that the findings will inform on-going research, includ-
ing trials that aim to alter body size trajectories and
stimulate new lines of investigation. This grant is also
potentially relevant to a wide range of clinicians.
Child growth assessment is a fundamental part of
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routine care in the UK and, by providing a better
understanding of the role of growth and development
in cardio-metabolic disease aetiology, our findings
have the potential to impact on this practice and the
guidelines on what constitutes healthy growth and
development. Obesity clinics and cardiologists alike
may also benefit from an improved understanding of
which patients are likely to suffer most from the
cardio-metabolic complications of obesity, based on
their body size trajectory and other life course expo-
sures. Findings could also potentially be used to aug-
ment recommendations to parents and their children
on how to maximise long-term cardio-metabolic
health. Of course, the end goal of this grant is to pro-
vide a stronger literature base to inform policy and
practice, as a means to impact on public health and
wellbeing. In particular, the results may be informative
for characterising which individuals should be targeted
for healthcare provision or therapeutic intervention
and may be exploited for new evidence-based inter-
ventions that improve disease processes.
To ensure maximum coverage and impact on the
scientific and medical community, the results will be
disseminated in publications and at international con-
ferences. A collaborative group has been formed, and
their steering and mentorship will naturally increase the
impact of these outputs. Further, planned communica-
tion with organisations such as Public Health England
will help ensure that the results are translational. A
well-thought-out series of three workshops has been
designed to provide training (e.g. to UK PhD students
and postdocs on ‘cross cohort analysis of secular trends
in longitudinal processes and relationships’) and
increase dissemination and discussion of results. The
grant is fully integrated into CLOSER and the institu-
tions who house the studies, which will help (1) WJ
strengthen his link with the UK birth cohorts, (2) facili-
tate communication with the wider academic and
non-academic community and (3) hopefully benefit the
end-user of birth cohort study data (e.g. by feeding back
harmonised data sets and guides to key stakeholders).
Finally, the grant incorporates numerous training and
learning opportunities for the Principal Investigator and
employed Research Associate and, as such, will have
significant impacts on their career trajectories.
Conclusions
Individuals who are obese have different cardio-
metabolic health and disease risks, as do individuals
who are normal weight, but very little is known about
the life course exposures and processes that explain
this heterogeneity. Primarily using data from the UK
birth cohort studies, this grant will provide novel evi-
dence on the body size trajectories, patterns of puber-
tal development, and other factors (e.g. early-life
adversity) that lead to some people developing a
cardio-metabolic complication or disease or dying
while other people with the same BMI do not.
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